Better Therapeutics begins ‘real world’ study of digital diabetes therapyAfter announcing plans to go public, prescription digital therapeutics (DTx) firm Better Therapeutics has begun a “real world” Share XBetter Therapeutics begins ‘real world’ study of digital diabetes therapyhttps://pharmaphorum.com/news/better-therapeutics-begins-real-world-study-of-digital-diabetes-therapy/
Microsoft puts AI at heart of digital health strategy with Nuance dealMicrosoft has made its aspirations in digital health clear with a whopping $19.7 billion deal to buy Nuance Share XMicrosoft puts AI at heart of digital health strategy with Nuance dealhttps://pharmaphorum.com/news/microsoft-puts-ai-at-heart-of-digital-health-strategy-with-nuance-deal/
AXA partners Microsoft on ‘all-in-one’ digital health platformEuropean insurance giant AXA has stepped up an alliance with Microsoft to develop an international digital health platform Share XAXA partners Microsoft on ‘all-in-one’ digital health platformhttps://pharmaphorum.com/news/axa-partners-microsoft-on-all-in-one-digital-health-platform/
AI device cleared by FDA to spot lesions during colonoscopyThe FDA has approved the first artificial intelligence-powered device that can be used to help identify colorectal lesions Share XAI device cleared by FDA to spot lesions during colonoscopyhttps://pharmaphorum.com/news/ai-device-cleared-by-fda-to-spot-lesions-during-colonoscopy/
Apple, Google block NHS contact tracing app update on privacy groundsA scheduled update to the NHS COVID-19 app has been blocked because it allows location tracking – something Share XApple, Google block NHS contact tracing app update on privacy groundshttps://pharmaphorum.com/news/apple-google-block-nhs-contact-tracing-app-update-on-privacy-grounds/
Exscientia starts trials of first AI-derived cancer immunotherapyExscientia was the first company to start human trials of a new drug designed using artificial intelligence (AI) Share XExscientia starts trials of first AI-derived cancer immunotherapyhttps://pharmaphorum.com/news/exscientia-starts-trials-of-first-ai-derived-cancer-immunotherapy/
Healx deploys its AI in hunt for Friedreich’s ataxia therapiesUK artificial intelligence specialist Healx has begun a partnership with two medical charities that aims to uncover new Share XHealx deploys its AI in hunt for Friedreich’s ataxia therapieshttps://pharmaphorum.com/news/healx-deploys-its-ai-in-hunt-for-friedreichs-ataxia-therapies/
Digital tool will be tested against COVID-19 ‘brain fog’A digital tool used to treat attention-deficit hyperactivity disorder (ADHD) is being tested to see if it can Share XDigital tool will be tested against COVID-19 ‘brain fog’https://pharmaphorum.com/news/digital-tool-will-be-tested-against-covid-19-brain-fog/
FDA green lights Oxehealth vital signs monitoring softwareUK digital health company Oxehealth has claimed FDA approval for software that can be used to remotely measure Share XFDA green lights Oxehealth vital signs monitoring softwarehttps://pharmaphorum.com/news/fda-green-lights-oxehealth-vital-signs-monitoring-software/
